P. Wells

发表

Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists

R. Abagyan, R. Stevens, Wei Liu, 2010, Science.

Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.

P. Wells, C. Toris, Chau Almaden, 2011, Experimental eye research.

Ocular pharmacokinetics and hypotensive activity of PF-04475270, an EP4 prostaglandin agonist in preclinical models.

P. Wells, E. Rui, Chau Almaden, 2009, Experimental eye research.

Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation

Krister Wennerberg, Peter Wells, Olli Kallioniemi, 2015, Nature.

Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors.

P. Kung, S. Yamazaki, M. Edwards, 2016, Journal of medicinal chemistry.

Design and Synthesis of Pyridone-Containing 3 , 4-Dihydroisoquinoline-1 ( 2 H ) ‐ ones as a Novel Class of Enhancer of Zeste Homolog 2 ( EZH 2 ) Inhibitors

P. Kung, S. Yamazaki, M. Edwards, 2016 .

New concepts in coagulation.

P. Wells, G. Rock, 1997, Critical reviews in clinical laboratory sciences.

Correction to Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors.

P. Kung, S. Yamazaki, M. Edwards, 2016, Journal of Medicinal Chemistry.

Discovery of a novel class of targeted kinase inhibitors that blocks protein kinase C signaling and ameliorates retinal vascular leakage in a diabetic rat model.

K. Liu, P. Tran, P. Wells, 2010, European journal of pharmacology.

Beili Wu Cyclic Peptide Antagonists Structures of the CXCR 4 Chemokine GPCR with Small-Molecule and

R. Abagyan, R. Stevens, Wei Liu, 2011 .

Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation

O. Kallioniemi, K. Wennerberg, M. McTigue, 2015, Nature.